The fight against Covid got significantly easier on November 5th 2021 when Pfizer announced the successful result of their Phase II/III trial of Paxlovid, a new oral at-home treatment for Covid. When started 3 days from on set of symptoms for individual with high risk of developing severe symptom, hospitalization rate dropped 89% and resulted…